Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 1 ~ 20 of 26059, Page 1 of 1304
1. WHO calls for urgent action to reduce patient harm in healthcare
09/13/2019 WHO
2. Abbott''s Revolutionary FreeStyle® Libre System Now Reimbursed in the Two Largest Provinces in Canada
Provides broader access to FreeStyle Libre system for residents living with diabetes in Ontario and Quebec
09/13/2019 Abbott
3. Young Adult Persists, Gets Help for Hodgkin Lymphoma
When Katie Dimmock, 26, learned she had cancer, she was actually a little relieved. “It was one of the worst ? but at the same time best ? moments,” said Dimmock.
09/12/2019 American Cancer Society
4. Abbott Declares 383rd Consecutive Quarterly Dividend
ABBOTT PARK, Ill., Sept. 12, 2019 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 32 cents per share.
09/12/2019 Abbott
5. Seven Private Practice Physicians Win Support for Big Data Projects to Benefit Their Patients
Ophthalmologists to use the Academy's IRIS Registry database to investigate rare and common eye diseases
09/11/2019 American Academy of Ophthalmology
6. Abbott Announces New Data That Shows Artificial Intelligence Technology Can Help Doctors Better Determine Which Patients are Having a Heart Attack
New research found Abbott's algorithm created through machine learning could give doctors a more individualized calculation, leveraging factors such as age, sex and the changing dynamics of troponin protein levels in the blood, to improve heart attack diagnosis / This technology is the first machine learning developed algorithm that combines high sensitive troponin testing with other patient details to help doctors better determine if a heart attack is occurring
09/10/2019 Abbott
7. Pooled Analysis Continues to Show Merck’s KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Patients with Advanced NSCLC Whose Tumors Do Not Express PD-L1
Findings from Pooled Analysis of KEYNOTE-189, KEYNOTE-407 and KEYNOTE-021 (Cohort G) Presented at the IASLC 2019 World Conference on Lung Cancer
09/10/2019 MERCK
8. Merck Announces First Nine “Safer Childbirth Cities” Committed to Reducing Maternal Deaths and Narrowing Disparities in the US
Co-Funders Join Merck for Mothers to Support Newly Formed City-Based Coalitions
09/10/2019 MERCK
9. Why We Screen for Some Cancers and Not Others
Screening tests are powerful tools in helping find cancer early or even preventing it. But they aren’t perfect. Find out what’s behind guidelines that tell us what screening tests to get and when.
09/09/2019 American Cancer Society
10. Ministry of Health of Rwanda, Society for Family Health Rwanda and Abbott Launch Pioneering Model of Primary Health Care Service Delivery in Rwanda
New initiative will provide vital primary care services within a 30-minute walk of all Rwandans' homes / Health post workers will test and treat pregnant women for multiple infectious diseases that can have serious health consequences for both mothers and newborns if not diagnosed and treated early
09/09/2019 Abbott
11. The American Association of Neurological Surgeons and the American Academy of Orthopaedic Surgeons Join Forces to Create the American Spine Registry
Partnership unites practitioners with commitment to improving quality and delivery of patient care
09/09/2019 American Academy of Orthopaedic Surgeons
12. CDC Warns Against Vaping During Lung Illness Investigation
Federal experts are investigating reports of severe lung illnesses in people who used e-cigarettes (also known as vaping).
09/09/2019 American Cancer Society
13. Suicide: one person dies every 40 seconds
09/09/2019 WHO
14. Pivotal New Data from Merck’s Broad Oncology Portfolio at ESMO 2019 Congress
Phase 3 Data for KEYTRUDA® (pembrolizumab) as Neoadjuvant Therapy in Combination with Chemotherapy in Patients with Triple-Negative Breast Cancer (KEYNOTE-522) to be Featured in ESMO Presidential Symposium and Official Press Program Data for LYNPARZA Included in ESMO Presidential Symposium and Official Press Program: in Metastatic Castration-Resistant Prostate Cancer (PROfound) and in Advanced Ovarian Cancer (PAOLA-1)
09/09/2019 MERCK
15. PAHO Supports Bahamas Response with Emergency Medical Teams
09/08/2019 WHO
16. PAHO issues $3.5 million donor appeal for humanitarian health response in the Bahamas
The Pan American Health Organization (PAHO) is requesting an initial US $3.5 million from donors to cover short-term health care and other needs for the population in the Bahamas affected by Hurricane Dorian.
09/08/2019 WHO
17. Bahamas Health Officials Respond to Hurricane Dorian with PAHO’s support
09/08/2019 WHO
18. Accelerate efforts to eliminate cervical cancer
09/06/2019 WHO
19. Providers to Congress: Protect Patients from Surprise Bills Without Compromising Access to Care
09/06/2019 American Academy of Orthopaedic Surgeons
20. He''s Back and He''s Hydrated: Abbott and NFL Star Odell Beckham Jr. Partner for Pedialyte®
Beckham will serve as spokesperson and creative director for Pedialyte / Pedialyte provides advanced rehydration, with an optimal balance of electrolytes and glucose
09/06/2019 Abbott
1 2 3 4 5 6 7 8 9 10
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱